TY  - GEN
AU  - Huynh,Hung
AU  - Chow,Pierce K H
AU  - Palanisamy,Nallasivam
AU  - Salto-Tellez,Manuel
AU  - Goh,Boon Cher
AU  - Lee,Chi Kuen
AU  - Somani,Anaji
AU  - Lee,How Sung
AU  - Kalpana,Ramnarayanan
AU  - Yu,Kun
AU  - Tan,Puay Hoon
AU  - Wu,Jeanie
AU  - Soong,Richie
AU  - Lee,Ming Hui
AU  - Hor,Henley
AU  - Soo,Khee Chee
AU  - Toh,Han Chong
AU  - Tan,Patrick
TI  - Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
SN  - 0168-8278
PY  - 2008///1008
KW  - Angiogenesis Inhibitors
KW  - pharmacology
KW  - Animals
KW  - Antibiotics, Antineoplastic
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Bevacizumab
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Disease Models, Animal
KW  - Drug Therapy, Combination
KW  - Liver Neoplasms
KW  - Mechanistic Target of Rapamycin Complex 1
KW  - Mice
KW  - Mice, SCID
KW  - Multiprotein Complexes
KW  - Proteins
KW  - Signal Transduction
KW  - drug effects
KW  - Sirolimus
KW  - Survival Rate
KW  - TOR Serine-Threonine Kinases
KW  - Transcription Factors
KW  - metabolism
KW  - Vascular Endothelial Growth Factor A
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jhep.2008.02.022
ER  -